NeoDynamics offers hands on experience with NeoNavia at Swedish scientific meeting
The MedTech company NeoDynamics AB (publ) is present at the national spring meeting of SFBR, the Swedish Association of Breast Radiologists. After two years of virtual meetings, NeoDynamics can finally offer hands on training at workshops with their novel breast biopsy product NeoNavia, during the two days Radiologists meet up in Stockholm 12-13th of May.
At the meeting, breast radiology professionals get together to share scientific news and to hear about the latest developments in their field. A team from NeoDynamics headed by CEO Anna Eriksrud offers workshops in-between the sessions, to allow clinicians to try the product hands-on. The product is being met with great interest, as SFBR gathers the top Radiologists in Sweden.
“It has been with great interest that I have followed the development of NeoDynamics and the NeoNavia biopsy system – and great to arrange for training during coffee and lunch breaks. I was one of the first to test and use NeoNavia, a precision biopsy instrument that allowed me to make the procedure much more efficient,” says Edward Azavedo, Associate professor at Karolinska University Hospital in Sweden, and co-founder of the society and participant at the meeting.
NeoNavia is an innovative biopsy system built on a patented pulse technology for controlled and precise needle insertion, and is based on research at the Karolinska Institutet in Sweden. The system was developed by NeoDynamics AB and is currently being commercially introduced into the first markets.
For further information, please contact:
CEO Anna Eriksrud, phone +46 708 444 966 or e-mail [email protected]
CFO Aaron Wong, phone +46 735 972 011 or e-mail [email protected]
About NeoDynamics
NeoDynamics AB (publ) is a Swedish Medical Technology Company dedicated to advancing diagnosis and care of breast cancer. The company’s first product NeoNavia®, a new innovative pulse biopsy system for ultrasound guided tissue sampling, is currently being introduced to the market. The biopsy system is built on a patented pulse technology, based on research at the Karolinska Institutet in Sweden. NeoNavia is evaluated for breast cancer diagnosis at leading clinics in UK, Germany, and Sweden. The pulse biopsy system has been used for tissue sampling in breast and axilla in over 500 patients.
About NeoNavia
NeoNavia is a modern biopsy system with a completely new patented pulse technology intended for ultrasound-guided tissue sampling. It consists of a base unit, a handheld driver and three different types of biopsy needles. Each needle type is driven by the pulse technology providing a more controlled needle insertion and precise placement of the needle in the tumour whilst enabling high-quality tissue samples from both breasts and lymph nodes. The pulse biopsy system NeoNavia is designed to offer clinicians and patients accurate lesion targeting and high tissue yield for correct diagnosis and individualized treatment.